CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- 4 Planned sale CHIEF OPERATING OFFICER sold 12,470 shares at an average $41.24 ($514,224)
- 144 Insider Sale of Securities
- 4 Gift CHAIRMAN & CEO gave 171,794 shares (gift)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 19,900 shares at $40.94 ($814,706)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 82,542 shares at $37.14 ($3,065,610)
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 100 shares at $41.00 ($4,100)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale CHAIRMAN & CEO sold 257,969 shares at an average $38.86 ($10,023,532)
- 4 Planned sale CHIEF ACCOUNTING OFFICER sold 50,490 shares at an average $38.87 ($1,962,781)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF OPERATING OFFICER sold 12,368 shares at an average $37.67 ($465,843)
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes CHIEF ACCOUNTING OFFICER gave up 85 shares (to pay taxes)
- 4 Planned sale CHIEF OPERATING OFFICER sold 42,000 shares at $38.33 ($1,609,860)
Page 6 of 39 · 778 filings